| ADVERUM BIOTECHNOLOGIES |
| USA |
| Gesundheit |
| US00773U2078 / A404YL |
| AVU0 (Frankfurt) / ADVM (NASDAQ) |
| FRA:AVU0, ETR:AVU0, AVU0:GR, NASDAQ:ADVM |
| - |
| https://adverum.com/ |
|
Adverum Biotechnologies, Inc. is a biotechnology c..
>Volltext.. |
| 81.99 Mio. EUR |
| 135.56 Mio. EUR |
| - |
| -160.32 Mio. EUR |
| -157.4 Mio. EUR |
| -7.3 EUR |
| 75.76 Mio. EUR |
| 22.2 Mio. EUR |
| -117.46 Mio. EUR |
| 0.58 |
| -100% |
| -86.31% |
| - |
| - |
| - |
| ADVERUM |
| 16.12.25 |
|